GlucoTrack Inc (GCTK)vsIntuitive Surgical Inc (ISRG)
GCTK
GlucoTrack Inc
$0.47
-10.19%
HEALTHCARE · Cap: $1.91M
ISRG
Intuitive Surgical Inc
$375.20
-0.40%
HEALTHCARE · Cap: $131.94B
Smart Verdict
WallStSmart Research — data-driven comparison
ISRG leads profitability with a 28.4% profit margin vs 0.0%. GCTK trades at a lower P/E of 0.1x. ISRG earns a higher WallStSmart Score of 66/100 (B-).
GCTK
Avoid26
out of 100
Grade: F
ISRG
Strong Buy66
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for GCTK.
Margin of Safety
+80.5%
Fair Value
$1922.89
Current Price
$375.20
$1547.69 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Conservative balance sheet, low leverage
Strong operational efficiency at 33.6%
Safe zone — low bankruptcy risk
Large-cap with strong market position
Keeps 28 of every $100 in revenue as profit
18.5% revenue growth
Earnings expanding 26.5% YoY
Areas to Watch
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Expensive relative to growth rate
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : GCTK
The strongest argument for GCTK centers on P/E Ratio, Debt/Equity.
Bull Case : ISRG
The strongest argument for ISRG centers on Operating Margin, Altman Z-Score, Market Cap. Profitability is solid with margins at 28.4% and operating margin at 33.6%. Revenue growth of 18.5% demonstrates continued momentum.
Bear Case : GCTK
The primary concerns for GCTK are Revenue Growth, EPS Growth, Market Cap.
Bear Case : ISRG
The primary concerns for ISRG are PEG Ratio, P/E Ratio.
Key Dynamics to Monitor
GCTK profiles as a value stock while ISRG is a growth play — different risk/reward profiles.
ISRG carries more volatility with a beta of 1.46 — expect wider price swings.
ISRG is growing revenue faster at 18.5% — sustainability is the question.
ISRG generates stronger free cash flow (948M), providing more financial flexibility.
Bottom Line
ISRG scores higher overall (66/100 vs 26/100), backed by strong 28.4% margins and 18.5% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
GlucoTrack Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
GlucoTrack, Inc., a medical device company, designs, develops and markets noninvasive glucose monitoring devices for people with diabetes and prediabetes in Europe and Asia Pacific. The company is headquartered in Or Yehuda, Israel.
Visit Website →Intuitive Surgical Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.
Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?